Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04923568 · ClinicalTrials.gov registry record · NA

VR and Chronic Pain Pilot Usability Study

A NA study of Chronic Pain, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04923568: Completed NA study of Chronic Pain, sponsored by Albert Einstein College of Medicine.

NCT04923568 is a NA study of Chronic Pain that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 16 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04923568, a NA study of Chronic Pain, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This is a pilot feasibility and usability study of a virtual reality device for patients with chronic pain.

Primary Outcome

We will determine feasibility by measuring the % of participants that are contacted who are enrolled.

Conditions Studied

Interventions

  • DEVICE EaseVRx

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-08-03
Est. Completion 2022-10-07
Phase NA
Albert Einstein College of Medicine

175 total trials

What the finished NCT04923568 record still lists

NCT04923568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which EaseVRx is the first listed.

NCT04923568 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04923568 about?

NCT04923568 is a clinical study titled "VR and Chronic Pain Pilot Usability Study". This is a pilot feasibility and usability study of a virtual reality device for patients with chronic pain.

What is the current status of trial NCT04923568?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-08-03. Estimated completion is 2022-10-07.

What conditions does trial NCT04923568 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT04923568?

The interventions under investigation include: EaseVRx (DEVICE).

Who is sponsoring clinical trial NCT04923568?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04923568 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04923568's enrollment target sits among peer trials

16 280th of 301 higher than 22 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04923568, the US trial registry maintained by the National Library of Medicine. NCT04923568 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.